Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

BioNeutra Global Corporation (BGACF)

Compare
0.0670
+0.0063
+(10.29%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for BGACF
  • Previous Close 0.0000
  • Open 0.0601
  • Bid 0.0206 x --
  • Ask 0.0323 x --
  • Day's Range 0.0601 - 0.0601
  • 52 Week Range 0.0601 - 0.0670
  • Volume 4,943
  • Avg. Volume 0
  • Market Cap (intraday) 3.112M
  • Beta (5Y Monthly) 1.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Apr 26, 2025 - May 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products, with a focus on oligosaccharides. The company offers isomaltooligosaccharide ingredients under the VitaFiber brand, that provides low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers through direct-to-consumer retail channels, as well as through online retailers in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.

www.bioneutra.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BGACF

View More

Performance Overview: BGACF

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

BGACF
0.00%
S&P/TSX Composite index (^GSPTSE)
4.19%

1-Year Return

BGACF
10.29%
S&P/TSX Composite index (^GSPTSE)
6.68%

3-Year Return

BGACF
46.40%
S&P/TSX Composite index (^GSPTSE)
8.25%

5-Year Return

BGACF
35.58%
S&P/TSX Composite index (^GSPTSE)
66.50%

Compare To: BGACF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BGACF

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    987.92k

  • Enterprise Value

    5.77M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.62%

  • Return on Assets (ttm)

    -3.44%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    10.86M

  • Net Income Avi to Common (ttm)

    -610.21k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    796.54k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.26M

Research Analysis: BGACF

View More

Company Insights: BGACF

Research Reports: BGACF

View More

People Also Watch